Literature DB >> 6282208

Multiple-dose pharmacokinetics of amdinocillin in healthy volunteers.

S L Barriere, J G Gambertoglio, E T Lin, J E Conte.   

Abstract

The pharmacokinetics of amdinocillin (mecillinam) after multiple intravenous doses to healthy subjects are described. Assay of plasma and urine samples was carried out with a sensitive and specific high-pressure liquid chromatographic technique. A dose of 10 mg/kg of body weight was administered every 4 h for six doses. No accumulation was noted. Mean peak plasma concentrations were approximately 50 micrograms/ml, and the plasma half-life was approximately 53 min. Total plasma clearance was 4.6 ml/min per kg after the first dose, which declined slightly to 4.1 ml/min per kg after the last dose. Renal clearance remained fairly constant at approximately 2.9 ml/min per kg, or twice the creatinine clearance. The fraction excreted unchanged totaled 63% during the 4-h interval after the first dose and was nearly 70% overall. The steady-state volume of distribution was calculated to be 0.26 liter/kg. Urinary concentrations of amdinocillin were far in excess of the usual inhibitory concentrations for susceptible pathogens and were as high as 3,000 micrograms/ml. Dose of amdinocillin every 4 h provide plasma and urine concentrations which should be effective for the treatment of infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282208      PMCID: PMC181828          DOI: 10.1128/AAC.21.1.54

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Bacteriology and pharmacokinetics of the new amidino penicillin-mecillinam.

Authors:  J D Williams; J Andrews; M Mitchard; M J Kendall
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

2.  In vitro activity of mecillinam against anaerobic bacteria.

Authors:  G E Steinkraus; L R McCarthy
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

3.  Noncompartmental determination of the steady-state volume of distribution.

Authors:  L Z Benet; R L Galeazzi
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

4.  Mecillinam and ampicillin separately or combined in gram-negative septicemia.

Authors:  E Ekwall; A Scheja; S Cronberg; K Ganrot-Norlin; M Jonsson; I Juhlin; G Kahlmeter; A Thorén; K E Thulin; G Tunevall
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Pharmacokinetics of mecillinam in health subjects.

Authors:  J G Gambertoglio; S L Barriere; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

6.  Activity of mecillinam alone and in combination with other beta-lactam antibiotics.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

  6 in total
  2 in total

1.  Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency.

Authors:  I H Patel; L D Bornemann; V M Brocks; L S Fang; N E Tolkoff-Rubin; R H Rubin
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

2.  Pharmacokinetics of amdinocillin in healthy adults.

Authors:  B R Meyers; J Jacobson; J Masci; E Srulevitch; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.